Anesiva Announces Going Concern Opinion and Nasdaq Notice
...tements or to its annual report on Form 10-K. anesiva also announced that it received a letter on March ...e Nasdaq rules upon which it is based. About anesiva Anesiva, Inc. seeks to be a leader in the deve...c, moderate-to-severe pain. In December 2008, anesiva announced that a Phase 3 clinical trial of Adlea a...Anesiva Announces Planned Rights Offering
...uld if fully subscribed, produce gross proceeds to anesiva of an aggregate principal amount of $3,000,000. anesiva will be distributing non-transferable rights to su...amount of notes, for each share of common stock of anesiva owned as of 5:00 p.m., Pacific time, on the Record...Child Life Council Urges Parents to Think Ahead to Ease Child's Hospital Visit
... Washington, D.C., 2006. (2) Wong DL and Baker CM. Pain in Children: Comparison of Assessment Scales. Pediatric Nursing. 1988;14:9-17. (3) anesiva data on file. (4) Zempsky WT, Bean-Lijewski J, Kauffman RE et al. Needlefree Powder Lidocaine Delivery System Provides Rapid Effective Analgesia...Anesiva Announces May 22, 2008 Presentation at Citi Investment Research Global HealthCare Conference
...sure adequate time for any software download that may be necessary. About anesiva and its Diverse Pipeline of Pain Products Anesiva, Inc. is a late-stage b...nical trials for site-specific, acute and chronic, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more information about Anesiva's l...Anesiva Announces Hiring of Sales Force for FDA-Approved Product Zingo(TM)
...clusion on hospital formularies and sales uptake." anesiva and Sagent have a co-promotion agreement for Zingo in the United States. The two anesiva sales directors are Joseph Levato and David Randal...ng new products and exceeding goals. Dave comes to anesiva from Elan Corporation where he spent 13 years, the...Anesiva Announces Upcoming Webcasts and Conference Participation
...nsure adequate time for any software download that may be necessary. About anesiva and its Diverse Portfolio of Pain Products Anesiva, Inc. is a late-stage b...erous mid-stage clinical trials for site-specific, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more information about Anesiva's l...Anesiva to Present at BIO InvestorForum on October 11, 2007
...nsure adequate time for any software download that may be necessary. About anesiva and its Diverse Portfolio of Pain Products Anesiva, Inc. is a late-stage b...erous mid-stage clinical trials for site-specific, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more information about Anesiva's l...Anesiva to Unveil Zingo(TM) Commercialization Plans
... in physicians' offices and clinical laboratories. anesiva also recently completed enrollment of a Phase 3 tr... the label beyond the pediatric population. About anesiva and its Diverse Portfolio of Pain Products Anesiv...trials for site-specific, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more info...Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
...A deadlines. As announced in November 2008, anesiva ceased Zingo commercial activities to focus on the...ment of acute pain following orthopedic surgeries. anesiva is seeking to license Zingo as well as the underly...echnology and intellectual property. About anesiva Anesiva, Inc. seeks to be a leader in the d...Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
... its Adlea registration strategy. "Since joining anesiva in mid-June, I have conducted an extensive review ...imately $0.7 million in the third quarter of 2008. anesiva believes that the restructuring and other cost red... million per year as compared to current levels. anesiva also provided the following updates directly relat...Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery
...nd. The trial is designed to enroll 74 patients. anesiva announced approval of its investigational new drug...ar in patients receiving Adlea or placebo. About anesiva and its Diverse Pipeline of Pain Products Anesiv...fic, acute and chronic, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more info...Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
...gement of acute pain following orthopedic surgery. anesiva plans to initiate a Phase 2 clinical trial of Adle...ar in patients receiving Adlea or placebo. About anesiva and its Diverse Pipeline of Pain Products Anesiv...novel pharmaceutical products for pain management. anesiva has one FDA-approved product, Zingo(TM), for the r...Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
...ians' offices and clinical laboratories. In March, anesiva submitted a supplemental New Drug Application with...l IV insertions and blood draws in adults. About anesiva and its Diverse Pipeline of Pain Products Anesiv...trials for site-specific, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more info...Anesiva Defines Regulatory Pathway for Adlea with FDA
...mg in total knee arthroplasty) will be evaluated. anesiva is focused on two lead indications for Adlea: mana... another trial in total hip replacement surgeries. anesiva expects to initiate the following additional trial...s to go home the same day of their surgery. About anesiva and its Diverse Portfolio of Pain Products Anesiv...Anesiva Receives NASDAQ Delisting Staff Determination Letter
...Market LLC ("NASDAQ") on March 27, 2009, informing anesiva that it was not in compliance with Marketplace Rul... NASDAQ Global Market. On July 17, 2009, anesiva received a letter from NASDAQ notifying anesiva that based on NASDAQ's further review of...Anesiva to Present at BioCentury Newsmakers Conference on September 4, 2008
...sure adequate time for any software download that may be necessary. About anesiva and its Diverse Pipeline of Pain Products Anesiva, Inc. is a late-stage b...cal trials for site-specific, acute and chronic, moderate-to-severe pain. anesiva is based in South San Francisco, CA. For more information about Anesiva's l...Anesiva Announces Second Quarter 2008 Financial Results and Update
...08 second quarter marked a significant advance for anesiva as we introduced Zingo(TM) in the U.S. pediatric h...ing the Zingo U.S. commercial launch in late June, anesiva began supplying hospitals in its target pediat...ivotal Phase 3 pediatric trials of Zingo. -- anesiva signed an exclusive Zingo licensing and distributi...Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children
...edures are performed annually in U.S. hospitals. anesiva and its co-promotion partner Sagent Pharmaceutical...s and meet anticipated increasing market demand. anesiva intends to grow a global brand for Zingo through g...agreements in other major markets are in progress. anesiva also has established a joint venture in China for ...